Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019)

Akebia Therapeutics (AKBA) has 7 years of Short-term Investments data on file, last reported at $245000.0 in Q4 2019.

• On a quarterly basis, Short-term Investments fell 99.58% year-over-year to $245000.0 in Q4 2019; TTM through Dec 2019 was $245000.0, a 99.58% decrease from a year earlier, with the FY2019 full-year figure at $245000.0, down 99.58% from the prior year.
• Short-term Investments for Q4 2019 stood at $245000.0, down from $22.7 million in the prior quarter.
• Over the last five years, Short-term Investments for AKBA reached as high as $240.1 million in Q3 2017 and fell as low as $245000.0 in Q4 2019.
• Historically, Short-term Investments has averaged $124.6 million across 5 years, with a median of $100.4 million in 2016.
• Across the five-year window, Short-term Investments soared 574.61% in 2015 and sank 99.58% in 2019, its largest moves.
• Year by year, Short-term Investments stood at $88.7 million in 2015, then dropped by 17.67% to $73.0 million in 2016, then jumped by 139.43% to $174.8 million in 2017, then sank by 66.57% to $58.4 million in 2018, then sank by 99.58% to $245000.0 in 2019.
• Per Business Quant data, the three most recent Short-term Investments figures were $245000.0 in Q4 2019, $22.7 million in Q3 2019, and $49.6 million in Q2 2019.